Systemic complications of status epilepticus - An update

Epilepsy and Behavior

Volumn 49, Issue , 2015, Pages 83-87

  Hocker, Sara ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac; Intensive care unit; Medical complications; Status epilepticus; Treatment

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CATECHOLAMINE; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; KETAMINE; MIDAZOLAM; PENTOBARBITAL; PROPOFOL; THIOPENTAL; VALPROIC ACID; ANTICONVULSIVE AGENT;

ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOTOXICITY; CATECHOLAMINE RELEASE; COMPARTMENT SYNDROME; COMPRESSION FRACTURE; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; EPILEPTIC STATE; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERAMMONEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPOTENSION; HYPOTHERMIA; HYPOXIA; INFECTION; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER TOXICITY; METABOLIC ACIDOSIS; PANCREAS DISEASE; PARALYTIC ILEUS; PROPOFOL INFUSION SYNDROME; RASH; RESPIRATION DEPRESSION; RESPIRATORY ACIDOSIS; RHABDOMYOLYSIS; SEDATION; SHOCK; SHOULDER DISLOCATION; TACHYCARDIA; TAKOTSUBO CARDIOMYOPATHY; THROMBOCYTE DISORDER; THROMBOSIS; TONGUE EDEMA; TREATMENT WITHDRAWAL; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; CRITICAL ILLNESS; HEART DISEASES; INTENSIVE CARE UNIT; SEIZURES; STATUS EPILEPTICUS; TRENDS;

ANIMALS; ANTICONVULSANTS; CRITICAL ILLNESS; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS; SEIZURES; STATUS EPILEPTICUS;

EID: 84938993418     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.04.024     Document Type: Article

References (35)

1. Wijdicks E.F., Hubmayr R.D. Acute acid-base disorders associated with status epilepticus. Mayo Clin Proc 1994, 69:1044-1046.
2. Vohra T.T., Miller J.B., Nicholas K.S., Varelas P.N., Harsh D.M., Durkalski V., et al. Endotracheal intubation in patients treated for prehospital status epilepticus. Neurocrit Care 2015.
3. Meierkord H., Shorvon S., Lightman S.L. Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure. Acta Neurol Scand 1994, 90:73-77.
4. Simon R.P., Aminoff M.J., Benowitz N.L. Changes in plasma catecholamines after tonic-clonic seizures. Neurology 1984, 34:255-257.
5. Bealer S.L., Little J.G., Metcalf C.S., Brewster A.L., Anderson A.E. Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus. Epilepsy Res 2010, 91(1):66-73.
6. Shimizu M., Kagawa A., Takano T., Masai H., Miwa Y. Neurogenic stunned myocardium associated with status epileptics and postictal catecholamine surge. Intern Med 2008, 47:269-273.
7. Manno E.M., Pfeifer E.A., Cascino G.D., Noe K.H., Wijdicks E.F. Cardiac pathology in status epilepticus. Ann Neurol 2005, 58(6):954-957.
8. Painter J.A., Shiel F.O., DeLorenzo R.J. Cardiac pathology findings in status epilepticus. Epilepsia 1993, 34(Suppl. 6):30.
9. Boggs J.G., Painter J.A., DeLorenzo R.J. Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res 1993, 14(1):87-94.
10. Hocker S., Prasad A., Rabinstein A.A. Cardiac injury in refractory status epilepticus. Epilepsia 2013, 54(3):518-522.
11. Wittstein I.S., Thiemann D.R., Lima J.A., Baughman K.L., Schulman S.P., Gerstenblith G., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352(6):539-548.
12. Soundarya N., Lawrence D., Samip J., Stacy A., Robert J., Leroy R., et al. Elevation of cardiac troponins in prolonged status epilepticus: a retrospective chart analysis. SOJ Neurol 2014, 1(1):1-4.
13. Mehrpour M., Hajsadeghi S., Fereshtehnejad S.M., Mehrpour M., Bassir P. Serum levels of cardiac troponin I in patients with status epilepticus and healthy cardiovascular system. Arch Med Res 2013, 44(6):449-453.
14. Sieweke N., Allendörfer J., Franzen W., Feustel A., Reichenberger F., Pabst W., Krämer H.H., Kaps M., Tanislav C. Cardiac troponin I elevation after epileptic seizure. BMC Neurol 2012, 12:58.
15. Little J.G., Bealer S.L. β adrenergic blockade prevents cardiac dysfunction following status epilepticus in rats. Epilepsy Res 2012, 99(3):233-239.
16. Stöllberger C., Wegner C., Finsterer J. Seizure-associated takotsubo cardiomyopathy. Epilepsia 2011, 52(11):e160-e167.
17. Benyounes N., Obadia M., Devys J.M., Thevenin A., Iglesias S. Partial status epilepticus causing a transient left ventricular apical ballooning. Seizure 2011, 20(2):184-186.
18. Legriel S., Bruneel F., Dalle L., Appere-de-Vecchi C., Georges J.L., Abbosh N., et al. Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus. Neurocrit Care 2008, 9(1):118-121.
19. Prasad A., Lerman A., Rihal C.S. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008, 155(3):408-417.
20. Cascino G.D., Hesdorffer D., Logroscino G., Hauser W.A. Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984. Mayo Clin Proc 2001, 76(1):39-41.
21. Alldredge B.K., Gelb A.M., Isaacs S.M., Corry M.D., Allen F., Ulrich S., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345(9):631-637.
22. Santamarina E., Toledo M., Sueiras M., Raspall M., Ailouti N., Lainez E., et al. Usefulness of intravenous lacosamide in status epilepticus. J Neurol 2013, 260(12):3122-3128.
23. Adams B.D., Buckley N.H., Kim J.Y., Tipps L.B. Fosphenytoin may cause hemodynamically unstable bradydysrhythmias. J Emerg Med 2006, 30(1):75-79.
24. Siebert W.J., McGavigan A.D. Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction?. Intern Med J 2013, 43(1):7-17.
25. Mayette M., Gonda J., Hsu J.L., Mihm F.G. Propofol infusion syndrome resuscitation with extracorporeal life support: a case report and review of the literature. Ann Intensive Care 2013, 3(1):32.
26. Diedrich D.A., Brown D.R. Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med 2011, 26:59-72.
27. Iyer V.N., Hoel R., Rabinstein A.A. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37:3024-3030.
28. Cereda C., Berger M.M., Rossetti A.O. Bowel ischemia: a rare complication of thiopental treatment for status epilepticus. Neurocrit Care 2009, 10(3):355-358.
29. Ji T., Zubkov A.Y., Wijdicks E.F., Manno E.M., Rabinstein A.A., Kotagal S. Massive tongue swelling in refractory status epilepticus treated with high-dose pentobarbital. Neurocrit Care 2009, 10:73-75.
30. Bledsoe K.A., Kramer A.H. Propylene glycol toxicity complicating use of barbiturate coma. Neurocrit Care 2008, 9:122-124.
31. Barnes B.J., Gerst C., Smith J.R., Terrell A.R., Mullins M.E. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 2006, 26:23-33.
32. Pugin D., Foreman B., De Marchis G.M., Fernandez A., Schmidt J.M., Czeisler B.M., et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care 2014, 18(3):R103.
33. Gaspard N., Foreman B., Judd L.M., Brenton J.N., Nathan B.R., McCoy B.M., et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013, 54(8):1498-1503.
34. Mirsattari S.M., Sharpe M.D., Young G.B. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004, 61:1254-1259.
35. Corry J.J., Dhar R., Murphy T., Diringer M.N. Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9:189-197.